{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:40:03Z","timestamp":1773283203035,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/ja.2008.31","type":"journal-article","created":{"date-parts":[[2009,1,16]],"date-time":"2009-01-16T14:53:33Z","timestamp":1232117613000},"page":"213-221","source":"Crossref","is-referenced-by-count":10,"title":["Genetic Analysis of Faropenem-resistant Enterococcus faecalis in Urinary Isolates"],"prefix":"10.1038","volume":"61","author":[{"given":"Noriyuki","family":"Hiraga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Muratani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFja200831_CR1","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1592\/phco.23.14.1497.31937","volume":"23","author":"M Jeremy","year":"2003","unstructured":"Jeremy M, Hamilton-Miller T . Chemical and microbiologic aspects of penems, a distinct class of beta-lactams: focus on faropenem. Pharmacotherapy 23: 1497\u20131507 ( 2003)","journal-title":"Pharmacotherapy"},{"key":"BFja200831_CR2","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.ijantimicag.2004.02.001","volume":"24S","author":"T Muratani","year":"2004","unstructured":"Muratani T, Matsumoto T . Bacterial resistance to antimicrobials in urinary isolates. Int J Antimicrob Agents 24S: S28\u2013S31 ( 2004)","journal-title":"Int J Antimicrob Agents"},{"key":"BFja200831_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1128\/CMR.13.4.686","volume":"13","author":"Y Cetinkaya","year":"2000","unstructured":"Cetinkaya Y, Falk P, Mayhall CG . Vancomycin-resistant enterococci. Clin Microbiol Rev 13: 686\u2013707 ( 2000)","journal-title":"Clin Microbiol Rev"},{"key":"BFja200831_CR4","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s00018-004-4060-9","volume":"61","author":"K Poole","year":"2004","unstructured":"Poole K . Resistance to beta-lactam antibiotics. Cell Mol Life Sci 61: 2200\u20132223 ( 2004)","journal-title":"Cell Mol Life Sci"},{"key":"BFja200831_CR5","doi-asserted-by":"publisher","first-page":"928","DOI":"10.11150\/kansenshogakuzasshi1970.76.928","volume":"76","author":"T Muratani","year":"2002","unstructured":"Muratani T, Iihara K, Nishimura T, Inatomi H, Fujimoto N, Kobayashi T, Yamada Y, Takahashi K, Matsumoto T . Faropenem 300 mg 3 times daily versus levofloxacin 100 mg 3 times daily in the treatment of urinary tract infections in patients with neurogenic bladder and\/or benign prostatic hypertrophy. Kansenshogaku Zasshi 76: 928\u2013938 ( 2002)","journal-title":"Kansenshogaku Zasshi"},{"key":"BFja200831_CR6","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.vaccine.2003.11.027","volume":"22","author":"S Koch","year":"2004","unstructured":"Koch S, Hufnagel M, Theilacker C, Huebner J . Enterococcal infections: host response, therapeutic, and prophylactic possibilities. Vaccine 22: 822\u2013830 ( 2004)","journal-title":"Vaccine"},{"key":"BFja200831_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.spid.2006.06.006","volume":"17","author":"M Karina","year":"2006","unstructured":"Karina M, Butler MB . Enterococcal infection in children. Semin Pediatr Infect Dis 17: 128\u2013139 ( 2006)","journal-title":"Semin Pediatr Infect Dis"},{"key":"BFja200831_CR8","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/archinte.1986.00360200111018","volume":"146","author":"AJ Morrison","year":"1986","unstructured":"Morrison AJ, Wenzel RP . Nosocomial urinary tract infections due to Enterococcus. Ten years' experience at a university hospital. Arch Intern Med 146: 1549\u20131551 ( 1986)","journal-title":"Arch Intern Med"},{"key":"BFja200831_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s101560050007","volume":"5","author":"S Takahashi","year":"1999","unstructured":"Takahashi S, Hirose T, Tsukamoto T, et al. Analysis of cross infection using genomic fingerprinting in nosocomial urinary tract infection caused by Enterococcus faecalis. J Infect Chemother 5: 46\u201348 ( 1999)","journal-title":"J Infect Chemother"},{"key":"BFja200831_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1067\/mic.2001.111537","volume":"29","author":"JM Langley","year":"2001","unstructured":"Langley JM, Hanakowski M, Leblanc JC . Unique epidemiology of nosocomial urinary tract infection in children. Am J Infect Control 29: 94\u201398 ( 2001)","journal-title":"Am J Infect Control"},{"key":"BFja200831_CR11","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00467-005-1976-8","volume":"20","author":"M Bitsori","year":"2005","unstructured":"Bitsori M, Maraki S, Galanakis E, et al. Community-acquired enterococcal urinary tract infections. Pediatr Nephrol 20: 1583\u20131586 ( 2005)","journal-title":"Pediatr Nephrol"},{"key":"BFja200831_CR12","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989\u20131993. J Am Med Assoc 270: 1796 ( 1993)","DOI":"10.1001\/jama.1993.03510150030010"},{"key":"BFja200831_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00001432-199508000-00009","volume":"8","author":"JP Burke","year":"1995","unstructured":"Burke JP . Hospitals enter the war against antibiotic resistance. Curr Opin Infect Dis 8: 269\u2013271 ( 1995)","journal-title":"Curr Opin Infect Dis"},{"key":"BFja200831_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/jac\/39.1.35","volume":"39","author":"JM Woodcock","year":"1997","unstructured":"Woodcock JM, Andrews JM, Wise R, et al. The in-vitro activity of faropenem, a novel oral penem. J Antimicrob Chemother 39: 35\u201343 ( 1997)","journal-title":"J Antimicrob Chemother"},{"key":"BFja200831_CR15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1172\/JCI111042","volume":"72","author":"BE Murray","year":"1983","unstructured":"Murray BE, Mederski-Samoraj B . A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Investig 72: 1168\u20131171 ( 1983)","journal-title":"J Clin Investig"},{"key":"BFja200831_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/clinids\/14.3.655","volume":"14","author":"S Handwerger","year":"1992","unstructured":"Handwerger S, Perlman DC, McAuliffe V . Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis 14: 655\u2013661 ( 1992)","journal-title":"Clin Infect Dis"},{"key":"BFja200831_CR17","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1128\/AAC.40.11.2550","volume":"40","author":"R Okamoto","year":"1996","unstructured":"Okamoto R, Okubo T, Inoue M . Detection of genes regulating beta-lactamase production in Enterococcus faecalis and Staphylococcus aureus. Antimicrob Agents Chemother 40: 2550\u20132554 ( 1996)","journal-title":"Antimicrob Agents Chemother"},{"key":"BFja200831_CR18","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1128\/AAC.30.6.861","volume":"30","author":"BE Murray","year":"1986","unstructured":"Murray BE, Church DA, Mederski-Samoraj B, et al. Comparison of two beta-lactamase producing strains of Streptococcus faecalis. Antimicrob Agents Chemother 30: 861\u2013864 ( 1986)","journal-title":"Antimicrob Agents Chemother"},{"key":"BFja200831_CR19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/163.4.780","volume":"163","author":"BE Murray","year":"1991","unstructured":"Murray BE, Singh KV, Goldstein FW, et al. Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus faecalis to six hospitals in five states. J Infect Dis 163: 780\u2013785 ( 1991)","journal-title":"J Infect Dis"},{"key":"BFja200831_CR20","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1099\/00221287-147-9-2561","volume":"147","author":"C Duez","year":"2001","unstructured":"Duez C, Zorzi W, Coyette J, et al. The penicillin resistance of Enterococcus faecalis JH2-2r results from an overproduction of the low-affinity penicillin-binding protein PBP4 and does not involve a psr-like gene. Microbiology 147: 2561\u20132569 ( 2001)","journal-title":"Microbiology"},{"key":"BFja200831_CR21","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1128\/AAC.40.10.2420","volume":"40","author":"E Cercenado","year":"1996","unstructured":"Cercenado E, Vicente MF, Sanchez-Rubiales M, et al. Characterization of clinical isolates of beta-lactamase-negative, highly ampicillin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 40: 2420\u20132422 ( 1996)","journal-title":"Antimicrob Agents Chemother"},{"key":"BFja200831_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s002039900133","volume":"173","author":"C Signoretto","year":"2000","unstructured":"Signoretto C, Canepari P . Paradoxical effect of inserting, in Enterococcus faecalis penicillin-binding protein 5, an amino acid box responsible for low affinity for penicillin in Enterococcus faecium. Arch Microbiol 173: 213\u2013219 ( 2000)","journal-title":"Arch Microbiol"},{"key":"BFja200831_CR23","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1128\/AAC.49.7.2954-2958.2005","volume":"49","author":"S Ono","year":"2005","unstructured":"Ono S, Muratani T, Matsumoto T . Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis. Antimicrob Agents Chemother 49: 2954\u20132958 ( 2005)","journal-title":"Antimicrob Agents Chemother"},{"key":"BFja200831_CR24","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1128\/JCM.39.6.2367-2368.2001","volume":"39","author":"S Elsayed","year":"2001","unstructured":"Elsayed S, Hamilton N, Mulvey M, et al. Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp. J Clin Microbiol 39: 2367\u20132368 ( 2001)","journal-title":"J Clin Microbiol"},{"key":"BFja200831_CR25","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/JCM.38.8.3092-3095.2000","volume":"38","author":"R Kariyama","year":"2000","unstructured":"Kariyama R, Mitsuhata R, Kumon H, et al. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol 38: 3092\u20133095 ( 2000)","journal-title":"J Clin Microbiol"},{"key":"BFja200831_CR26","unstructured":"National Committee for Clinical Laboratory Standards . Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa. ( 1993)"},{"key":"BFja200831_CR27","unstructured":"National Committee for Clinical Laboratory Standards . Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa. ( 2002)"},{"key":"BFja200831_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1128\/AAC.1.4.283","volume":"1","author":"CH O'Callaghan","year":"1972","unstructured":"O'Callaghan CH, Morris A, Shingler AH, et al. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1: 283\u2013288 ( 1972)","journal-title":"Antimicrob Agents Chemother"},{"key":"BFja200831_CR29","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/254516a0","volume":"254","author":"B Spratt","year":"1975","unstructured":"Spratt B, Pardee AB . Penicillin-binding proteins and cell shape in Escherichia coli. Nature 254: 516\u2013517 ( 1975)","journal-title":"Nature"},{"key":"BFja200831_CR30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Randall RJ, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265\u2013275 ( 1951)","journal-title":"J Biol Chem"},{"key":"BFja200831_CR31","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1128\/AAC.43.5.1124","volume":"43","author":"G Zhao","year":"1999","unstructured":"Zhao G, Meier TI, Blaszczak LC, et al. Bocillin FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins. Antimicrob Agents Chemother 43: 1124\u20131128 ( 1999)","journal-title":"Antimicrob Agents Chemother"},{"key":"BFja200831_CR32","first-page":"17","volume":"15","author":"ME Kaufmann","year":"1998","unstructured":"Kaufmann ME . Pulsed-field gel electrophoresis. Methods Mol Med 15: 17\u201331 ( 1998)","journal-title":"Methods Mol Med"},{"key":"BFja200831_CR33","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/JCM.33.9.2233-2239.1995","volume":"33","author":"FC Tenover","year":"1995","unstructured":"Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233\u20132239 ( 1995)","journal-title":"J Clin Microbiol"},{"key":"BFja200831_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s002030050632","volume":"170","author":"C Signoretto","year":"1998","unstructured":"Signoretto C, Boaretti M, Canepari P . Peptidoglycan synthesis by Enterococcus faecalis penicillin binding protein 5. Arch Microbiol 170: 185\u2013190 ( 1998)","journal-title":"Arch Microbiol"},{"key":"BFja200831_CR35","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1128\/AAC.36.11.2355","volume":"36","author":"BE Murray","year":"1992","unstructured":"Murray BE . Beta-lactamase-producing enterococci. Antimicrob Agents Chemother 36: 2355\u20132359 ( 1992)","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ja200831.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja200831","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja200831.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:13:24Z","timestamp":1684430004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja200831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["BFja200831"],"URL":"https:\/\/doi.org\/10.1038\/ja.2008.31","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}